Haberer, Lynda J.
11  results:
Search for persons X
?
1

Integration of modeling and simulation to support changes t..:

Zuo, Peiying ; Haberer, Lynda J. ; Fang, Lei...
The Journal of Clinical Pharmacology.  54 (2014)  11 - p. 1221-1229 , 2014
 
?
2

Single‐Dose Pharmacokinetics of the CCR9 Receptor Antagonis..:

Haberer, Lynda J. ; Hacquoil, Kimberley ; Ino, Hiroko...
Clinical Pharmacology in Drug Development.  2 (2013)  4 - p. 387-393 , 2013
 
?
3

Effects of vercirnon on the activity of CYP3A4, CYP2C19 and..:

Haberer, Lynda J. ; McSherry, Iain ; Cargill, Anna.
European Journal of Clinical Pharmacology.  70 (2013)  1 - p. 37-45 , 2013
 
?
4

Distinct Pharmacokinetic Profile and Safety of a Fixed‐Dose..:

Haberer, Lynda J. ; Walls, Christine M. ; Lener, Shelly E...
Headache: The Journal of Head and Face Pain.  50 (2010)  3 - p. 357-373 , 2010
 
?
5

Population pharmacokinetics of intravenous ondansetron in o..:

Mondick, John T. ; Johnson, Brendan M. ; Haberer, Lynda J....
European Journal of Clinical Pharmacology.  66 (2009)  1 - p. 77-86 , 2009
 
?
6

The Effect of 5α-Reductase Inhibition with Dutasteride and ..:

Amory, John K. ; Wang, Christina ; Swerdloff, Ronald S....
The Journal of Clinical Endocrinology & Metabolism.  92 (2007)  5 - p. 1659-1665 , 2007
 
?
8

Central nervous system uptake kinetics of pentylenetetrazol..:

Haberer, Lynda J. ; Pollack, Gary M.
Biopharmaceutics & Drug Disposition.  12 (1991)  1 - p. 59-71 , 1991
 
?
 
1-11